The team behind TOXsIgN has invested considerable time, resources, and effort into collecting, curating, processing, developing, and maintaining this web resource.
×
TSP48523-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to BRD-A43210826
TSA198590-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-A43210826
TSA198637-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-A43210826
TSA198689-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-A43210826
TSA198738-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-A43210826
TSA198791-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-A43210826
TSA198841-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-A43210826
TSA198889-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-A43210826
TSA198934-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-A43210826
TSF399808-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-A43210826 3.33 µM for 24.0 h 1 subfactor(s)
TSF399807-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-A43210826 10.0 µM for 24.0 h 1 subfactor(s)
TSF399809-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-A43210826 1.11 µM for 24.0 h 1 subfactor(s)
TSF399810-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-A43210826 0.37 µM for 24.0 h 1 subfactor(s)
TSF399811-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-A43210826 0.125 µM for 24.0 h 1 subfactor(s)
TSF399812-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-A43210826 0.04 µM for 24.0 h 1 subfactor(s)
TSF400122-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-A43210826 3.33 µM for 24.0 h 1 subfactor(s)
TSF400123-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-A43210826 1.11 µM for 24.0 h 1 subfactor(s)
TSF400121-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-A43210826 10.0 µM for 24.0 h 1 subfactor(s)
TSF400124-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-A43210826 0.37 µM for 24.0 h 1 subfactor(s)
TSF400125-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-A43210826 0.125 µM for 24.0 h 1 subfactor(s)
TSF400126-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-A43210826 0.04 µM for 24.0 h 1 subfactor(s)
TSF400438-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-A43210826 10.0 µM for 24.0 h 1 subfactor(s)
TSF400439-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-A43210826 3.33 µM for 24.0 h 1 subfactor(s)
TSF400440-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-A43210826 1.11 µM for 24.0 h 1 subfactor(s)
TSF400441-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-A43210826 0.37 µM for 24.0 h 1 subfactor(s)
TSF400442-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-A43210826 0.125 µM for 24.0 h 1 subfactor(s)
TSF400443-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-A43210826 0.04 µM for 24.0 h 1 subfactor(s)
TSF400754-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-A43210826 3.33 µM for 24.0 h 1 subfactor(s)
TSF400753-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-A43210826 10.0 µM for 24.0 h 1 subfactor(s)
TSF400757-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-A43210826 0.125 µM for 24.0 h 1 subfactor(s)
TSF400755-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-A43210826 1.11 µM for 24.0 h 1 subfactor(s)
TSF400756-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-A43210826 0.37 µM for 24.0 h 1 subfactor(s)
TSF400758-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-A43210826 0.04 µM for 24.0 h 1 subfactor(s)
TSF401074-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-A43210826 1.11 µM for 24.0 h 1 subfactor(s)
TSF401075-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-A43210826 0.37 µM for 24.0 h 1 subfactor(s)
TSF401072-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-A43210826 10.0 µM for 24.0 h 1 subfactor(s)
TSF401073-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-A43210826 3.33 µM for 24.0 h 1 subfactor(s)
TSF401076-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-A43210826 0.125 µM for 24.0 h 1 subfactor(s)
TSF401077-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-A43210826 0.04 µM for 24.0 h 1 subfactor(s)
TSF401391-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-A43210826 10.0 µM for 24.0 h 1 subfactor(s)
TSF401392-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-A43210826 3.33 µM for 24.0 h 1 subfactor(s)
TSF401393-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-A43210826 1.11 µM for 24.0 h 1 subfactor(s)
TSF401394-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-A43210826 0.37 µM for 24.0 h 1 subfactor(s)
TSF401395-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-A43210826 0.125 µM for 24.0 h 1 subfactor(s)
TSF401396-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-A43210826 0.04 µM for 24.0 h 1 subfactor(s)
TSF401714-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-A43210826 0.04 µM for 24.0 h 1 subfactor(s)
TSF401710-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-A43210826 3.33 µM for 24.0 h 1 subfactor(s)
TSF401709-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-A43210826 10.0 µM for 24.0 h 1 subfactor(s)
TSF401711-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-A43210826 1.11 µM for 24.0 h 1 subfactor(s)
TSF401712-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-A43210826 0.37 µM for 24.0 h 1 subfactor(s)
TSF401713-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-A43210826 0.125 µM for 24.0 h 1 subfactor(s)
TSF402023-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-A43210826 10.0 µM for 24.0 h 1 subfactor(s)
TSF402024-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-A43210826 3.33 µM for 24.0 h 1 subfactor(s)
TSF402025-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-A43210826 1.11 µM for 24.0 h 1 subfactor(s)
TSF402026-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-A43210826 0.37 µM for 24.0 h 1 subfactor(s)
TSF402027-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-A43210826 0.125 µM for 24.0 h 1 subfactor(s)
TSF402028-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-A43210826 0.04 µM for 24.0 h 1 subfactor(s)
TSS399816-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-A43210826 3.33 µM for 24.0 h
TSS399815-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-A43210826 10.0 µM for 24.0 h
TSS399817-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-A43210826 1.11 µM for 24.0 h
TSS399818-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-A43210826 0.37 µM for 24.0 h
TSS399819-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-A43210826 0.125 µM for 24.0 h
TSS399820-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-A43210826 0.04 µM for 24.0 h
TSS400130-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-A43210826 3.33 µM for 24.0 h
TSS400131-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-A43210826 1.11 µM for 24.0 h
TSS400129-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-A43210826 10.0 µM for 24.0 h
TSS400132-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-A43210826 0.37 µM for 24.0 h
TSS400133-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-A43210826 0.125 µM for 24.0 h
TSS400134-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-A43210826 0.04 µM for 24.0 h
TSS400446-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-A43210826 10.0 µM for 24.0 h
TSS400447-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-A43210826 3.33 µM for 24.0 h
TSS400448-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-A43210826 1.11 µM for 24.0 h
TSS400449-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-A43210826 0.37 µM for 24.0 h
TSS400450-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-A43210826 0.125 µM for 24.0 h
TSS400451-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-A43210826 0.04 µM for 24.0 h
TSS400762-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-A43210826 3.33 µM for 24.0 h
TSS400761-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-A43210826 10.0 µM for 24.0 h
TSS400765-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-A43210826 0.125 µM for 24.0 h
TSS400763-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-A43210826 1.11 µM for 24.0 h
TSS400764-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-A43210826 0.37 µM for 24.0 h
TSS400766-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-A43210826 0.04 µM for 24.0 h
TSS401082-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-A43210826 1.11 µM for 24.0 h
TSS401083-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-A43210826 0.37 µM for 24.0 h
TSS401080-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-A43210826 10.0 µM for 24.0 h
TSS401081-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-A43210826 3.33 µM for 24.0 h
TSS401084-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-A43210826 0.125 µM for 24.0 h
TSS401085-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-A43210826 0.04 µM for 24.0 h
TSS401399-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-A43210826 10.0 µM for 24.0 h
TSS401400-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-A43210826 3.33 µM for 24.0 h
TSS401401-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-A43210826 1.11 µM for 24.0 h
TSS401402-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-A43210826 0.37 µM for 24.0 h
TSS401403-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-A43210826 0.125 µM for 24.0 h
TSS401404-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-A43210826 0.04 µM for 24.0 h
TSS401722-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-A43210826 0.04 µM for 24.0 h
TSS401718-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-A43210826 3.33 µM for 24.0 h
TSS401717-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-A43210826 10.0 µM for 24.0 h
TSS401719-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-A43210826 1.11 µM for 24.0 h
TSS401720-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-A43210826 0.37 µM for 24.0 h
TSS401721-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-A43210826 0.125 µM for 24.0 h
TSS402031-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-A43210826 10.0 µM for 24.0 h
TSS402032-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-A43210826 3.33 µM for 24.0 h
TSS402033-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-A43210826 1.11 µM for 24.0 h
TSS402034-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-A43210826 0.37 µM for 24.0 h
TSS402035-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-A43210826 0.125 µM for 24.0 h
TSS402036-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-A43210826 0.04 µM for 24.0 h
TSP48523 - CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to BRD-A43210826
Public
https://clue.io/data/CMap2020#LINCS2020
Experimental design
No experimental design provided
Results
No results provided